Correction to Sanofi Article
11 Abril 2023 - 4:00AM
Dow Jones News
Sanofi SA and AstraZeneca PLC said Tuesday that Sanofi would
retain full commercial control on an antibody treatment for
respiratory syncytial virus in the U.S. "Sanofi Gets Full
Commercial Control on Virus Medication From AstraZeneca in U.S.,"
at 0624 GMT, misstated the day.
(END) Dow Jones Newswires
April 11, 2023 02:45 ET (06:45 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Astrazeneca (LSE:AZN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024